Posttranslational modifications as versatile regulators of parkin function

Current Medicinal Chemistry

Volumn 18, Issue 16, 2011, Pages 2477-2485

  Rubio De La Torre, E ^a   Gomez Suaga P ^a   Martinez Salvador M ^a   Hilfiker, S ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Dopamine; Localization; Neurodegeneration; Parkin; Parkinson's disease; Phosphorylation; Protein interaction; S nitrosylation; Signaling; Substrate; Ubiquitylation

Indexed keywords

DOPAMINE; PARKIN; PHOSPHOTRANSFERASE; UBIQUITIN;

ARTICLE; CELL FUNCTION; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; ENZYME SUBSTRATE COMPLEX; HUMAN; NEUROPROTECTION; NITROSATIVE STRESS; NITROSYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; UBIQUITINATION;

EID: 79957956855     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795843254     Document Type: Article

References (93)

1. Gasser, T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev. Mol. Med., 2009, 11, e22.
2. Hardy, J.; Lewis, P.; Revesz, T.; Lees, A.; Paisan-Ruiz, C. The genetics of Parkinson's syndromes: a critical review. Curr. Opin. Genet. Dev., 2009, 19, 254-265.
3. Lesage, S.; Brice, A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet., 2009, 18, R48-R59.
4. Dauer, W.; Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron, 2003, 39, 889-909. (Pubitemid 37130207)
5. Dawson, T.M.; Dawson, V.L. Rare genetic mutations shed light on the pathogenesis of Parkinson disease. J. Clin. Invest., 2003, 111, 145-155.
6. Kitada, T.; Asakawa, S.; Hattori, N.; Matsumine, H.; Yamamura, Y.; Minoshima, S.; Yokochi, M.; Mizuno, Y.; Shimizu, N. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392, 605-608. (Pubitemid 28207717)
7. Bonifati, V.; Rizzu, P.; Squitieri, F.; Krieger, E.; Vanacore, N.; van Swieten, J.C.; Brice, A.; van Duijn, C.M.; Oostra, B.; Meco, G.; Heutink, P. DJ-1 (PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol. Sci., 2003, 24, 159-160. (Pubitemid 37304291)
8. Valente, E.M.; Abou-Sleiman, P.M.; Caputo, V.; Muqit, M.M.; Harvey, K.; Gispert, S.; Ali, Z.; Del Turco, D.; Bentivoglio, A.R.; Healy, D.G.; Albanese, A.; Nussbaum, R.; Gonzalez-Maldonado, R.; Deller, T.; Salvi, S.; Cortelli, P.; Gilks, W.P.; Latchman, D.S.; Harvey, R.J.; Dallapiccola, B.; Auburger, G.; Wood, N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 2004, 304, 1158-1160. (Pubitemid 38661852)
9. Shimura, H.; Hattori, N.; Kubo, S.; Mizuno, Y.; Asakawa, S.; Minoshima, S.; Shimizu, N.; Iwai, K.; Chiba, T.; Tanaka, K.; Suzuki, T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet., 2000, 25, 302-305. (Pubitemid 30437317)
10. Passmore, L.A.; Barford, D. Getting into position: the catalytic mechanisms of protein ubiquitylation. Biochem. J., 2004, 379, 513-525. (Pubitemid 38703635)
11. Ikeda, F.; Dikic, I. Atypical ubiquitin chains: new molecular signals. EMBO Rep., 2008, 9, 536-542.
12. Xu, P.; Duong, D.M.; Seyfried, N.T.; Cheng, D.; Xie, Y.; Robert, J.; Rush, J.; Hochstrasser, M.; Finley, D.; Peng, J. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell, 2009, 137, 133-145.
13. Tan, J.M.; Wong, E.S.; Kirkpatrick, D.S.; Pletnikova, O.; Ko, H.S.; Tay, S.P.; Ho, M.W.; Troncoso, J.; Gygi, S.P.; Lee, M.K.; Dawson, V.L.; Dawson, T.M.; Lim, K.L. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum. Mol. Genet., 2008, 17, 431-439.
14. Glickman, M.H.; Chiechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev., 2002, 82, 373-428. (Pubitemid 34654457)
15. Zhang, Y.; Gao, J.; Chung, K.K.; Huang, H.; Dawson, V.L.; Dawson, T.M. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA, 2000, 97, 13354-13359.
16. Imai, Y.; Soda, M.; Inoue, H.; Hattori, N.; Mizuno, Y.; Takahashi, R. An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin. Cell, 2001, 105, 891-902. (Pubitemid 32635090)
17. Doss-Pepe, E.W.; Chen, L.; Madura, K. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains. J. Biol. Chem., 2005, 280, 16619-16624. (Pubitemid 41389118)
18. Matsuda, N.; Kitami, T.; Suzuki, T.; Mizuno, Y.; Hattori, N.; Tanaka, K. Diverse effects of pathogenic mutations of Parkin that catalyze multiple monoubiquitylation in vitro. J. Biol. Chem., 2006, 281, 3204-3209. (Pubitemid 43845931)
19. Moore, D.J. Parkin: a multifaceted ubiquitin ligase. Biochem. Soc. Trans., 2006, 34, 749-753.
20. Chin, L.S.; Olzmann, J.A.; Li, L. Parkin-mediated ubiquitin signalling in aggresome formation and autophagy. Biochem. Soc. Trans., 2010, 38, 144-149.
21. Geisler, S.; Holmstrom, K.M.; Skujat, D.; Fiesel, F.C.; Rothfuss, O.C.; Kahle, P.J.; Springer, W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol., 2010, 12, 119-131.
22. Winklhofer, K.F. The parkin protein as a therapeutic target in Parkinson's disease. Expert Opin. Ther. Targets, 2007, 11, 1543-1552. (Pubitemid 350285004)
23. Ulusoy, A.; Kirik, D. Can overexpression of parkin provide a novel strategy for neuroprotection in Parkinson's disease? Exp. Neurol., 2008, 212, 258-260.
24. Gu, Z.; Nakamura, T.; Lipton, S.A. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol., 2010, 41, 55-72.
25. Chung, K.K.; Thomas, B.; Li, X.; Pletnikova, O.; Troncoso, J.C.; Marsh, L.; Dawson, V.L.; Dawson, T.M. S-nitrosylation of parkin regulates ubiquitination and compromises parkińs protective function. Science, 2004, 304, 1328-1331. (Pubitemid 38697430)
26. Yao, D.; Gu, Z.; Nakamura, T.; Shi, Z.-Q.; Ma, Y.; Gaston, B.; Palmer, L.A.; Rockenstein, E.M.; Zhang, Z.; Masliah, E.; Uehara, T.; Lipton, S.A. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci USA, 2004, 101, 10810-10814. (Pubitemid 38955824)
27. Chung, K.K.K.; Dawson, V.L.; Dawson, T.M. Response to Comment on "Snitrosylation of parkin regulates ubiquitination and compromises parkińs protective function. Science, 2005, 308, 1870c.
28. Wang, C.; Ko, H.S.; Thomas, B.; Tsang, F.; Chew, K.C.; Tay, S.P.; Ho, M.W.; Lim, T.M.; Soong, T.W.; Pletnikova, O.; Troncoso, J.; Dawson, V.L.; Dawson, T.M.; Lim, K.L. Stress-induced alterations of parkin solubility promote parkin aggregation and compromise parkińs protective function. Hum. Mol. Genet., 2005, 14, 3885-3897. (Pubitemid 43020090)
29. Wong, E.S.P.; Tan, J.M.M.; Wang, C.; Zhang, Z.; Tay, S.-P.; Zaiden, N.; Ko, H.S.; Dawson, V.L.; Dawson, T.M.; Lim, K.L. Relative sensitivity of parkinand other cysteine-containing enzymes to stress-induced solubility alterations. J. Biol. Chem., 2007, 282, 12310-12318. (Pubitemid 47100679)
30. LaVoie, M.F.; Cortese, G.P.; Ostaszewski, B.L.; Schlossmacher, M.G. The effects of oxidative stress on parkin and other E3 ligases. J. Neurochem., 2007, 103, 2354-2368. (Pubitemid 350173558)
31. Zhou, C.; Huang, Y.; Przedborski, S. Oxidative stress in Parkinson's disease. Ann. NY Acad. Sci., 2008, 1147, 93-104.
32. Lotharius, J.; Brundin, P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci., 2002, 3, 932-942.
33. Jiang, H.; Ren, Y.; Zhao, J.; Feng, J. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum. Mol. Genet., 2004, 13, 1745-1754. (Pubitemid 39173443)
34. Winklhofer, K.F.; Henn, I.H.; Kay-Jackson, P.C.; Heller, U.; Tatzelt, J. Inactivation of parkin by oxidative stress and C-terminal truncations: a protective role of molecular chaperones. J. Biol. Chem., 2003, 278, 47199-47208. (Pubitemid 37452306)
35. LaVoie, M.J.; Ostaszewski, B.L.; Weihofen, A.; Schlossmacher, M.G.; Selkoe, D.J. Dopamine covalently modifies and functionally inactivates parkin. Nat. Med., 2005, 11, 1214-1221. (Pubitemid 43093669)
36. Yamamoto, A.; Friedlein, A.; Imai, Y.; Takahashi, R.; Kahle, P.J.; Haass, C. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J. Biol. Chem., 2005, 280, 3390-3399. (Pubitemid 40223802)
37. Avraham, E.; Rott, R.; Liani, E.; Szargel, R.; Engelender, S. Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation. J. Biol. Chem., 2007, 282, 12842-12850. (Pubitemid 47100582)
38. Rubio de la Torre, E.; Luzón-Toro, B.; Forte-Lago, I.; Minguez-Castellanos, A.; Ferrer, I.; Hilfiker, S. Combined kinase inhibition modulates parkin inactivation. Hum. Mol. Genet., 2009, 18, 809-823.
39. Ko, H.S.; Lee, Y.; Shin, J.H.; Karuppagounder, S.; Gadad, B.S.; Koleske, A.J.; Pletnikova, O.; Troncoso, J.C.; Dawson, V.L.; Dawson, T.M. Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkińs ubiquitination and protective function. Proc. Natl. Acad. Sci. USA, 2010, 107, 16691-16696.
40. Trempe, J.F.; Chen, C.X.Q.; Grenier, K.; Camacho, E.M.; Kozlov, G.; McPherson, P.S.; Gehring, K.; Fon, E.A. SH3 domains from a subset of BAR proteins define a Ubl-binding domain and implicate parkin in synaptic ubiquitination. Mol. Cell, 2009, 36, 1034-1047.
41. Sha, D.; Chin, L.S.; Li, L. Phosphorylation of parkin by Parkinson diseaselinked kinase PINK1 activates parkin E3 ligase function and NF-αB signaling. Hum. Mol. Genet., 2010, 19, 352-363.
42. Henn, I.H.; Bouman, L.; Schlehe, J.S.; Schlierf, A.; Schramm, J.E.; Wegener, E.; Nakaso, K.; Culmsee, C.; Berninger, B.; Krappmann, D.; Tatzelt, J.; Winklhofer, K.F. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J. Neurosci., 2007, 27, 1868-1878.
43. Olzmann, J.A.; Li, L.; Chudaev, M.V.; Chen, J.; Perez, F.A.; Palmiter, R.D.; Chin, S. Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6. J. Cell Biol., 2007, 178, 1025-1038. (Pubitemid 47443324)
44. Crews, C.M. Feeding the machine: mechanisms of proteasome-catalysed degradation of ubiquitinated proteins. Curr. Opin. Chem. Biol., 2003, 7, 534-539. (Pubitemid 37315787)
45. Marfany, G.; Denuc, A. To ubiquitinate or to deubiquitinate: it all depends on the partners. Biochem. Soc. Trans., 2008, 36, 833-838.
46. Hunter, T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol. Cell, 2007, 28, 730-738. (Pubitemid 350217067)
47. Staropoli, J.F.; McDermott, C.; Martinat, C.; Schulman, B.; Demireva, E.; Abeliovich, A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron, 2003, 37, 735-749. (Pubitemid 36288547)
48. Cardozo, T.; Pagano, M. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell. Biol., 2004, 5, 739-751. (Pubitemid 39208183)
49. Demand, J.; Alberti, S.; Patterson, C.; Hohfeld, J. Cooperation of a ubiquitin protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr. Biol., 2001, 11, 1569-1577. (Pubitemid 32978521)
50. Tsai, Y.C.; Fishman, P.S.; Thakor, N.V.; Oyler, G.A. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J. Biol. Chem., 2003, 278, 22044-22055. (Pubitemid 36792614)
51. Imai, Y.; Soda, M.; Hatakeyama, S.; Akagi, T.; Hashikawa, T.; Nakayama, K.I.; Takahashi, R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cell, 2002, 10, 55-67. (Pubitemid 34876562)
52. Kalia, S.K.; Lee, S.; Smith, P.D.; Liu, L.; Crocker, S.J.; Thorarinsdottir, T.E.; Glover, J.R.; Fon, E.A.; Park, D.S.; Lozano, A.M. BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. Neuron, 2004, 44, 931-945. (Pubitemid 39643090)
53. Morishima, Y.; Wang, A.M.; Yu, Z.; Pratt, W.B.; Osawa, Y.; Lieberman, A.P. CHIP deletion reveals functional redundancy of E3 ligases in promoting degradation of both signaling proteins and expanded glutamine proteins. Hum. Mol. Genet., 2008, 17, 3942-3952. (Pubitemid 352762855)
54. Xiong, H.; Wang, D.; Chen, L.; Choo, Y.S.; Ma, H.; Tang, C.; Xia, K.; Jiang, W.; Ronai, Z.; Zhuang, X.; Zhang, Z. Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation. J. Clin. Invest., 2009, 119, 650-660.
55. Beilina, A.; Van der Brug, M.; Ahmad, R.; Kesavapany, S.; Miller, D.W.; Petsko, G.A.; Cookson, M.R. Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc. Natl. Acad. Sci. USA, 2005, 102, 5703'5708.
56. Silvestri, L.; Caputo, V.; Bellacchio, E.; Atorino, L.; Dallapiccola, B.; Valente, E.M.; Casari, G. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum. Mol. Genet., 2005, 14, 3477-3492. (Pubitemid 41672130)
57. Narendra, D.P.; Jin, S.M.; Tanaka, A.; Suen, D.-F.; Gautier, C.A.; Shen, J.; Cookson, M.R.; Joule, R.J. PINK1 is selectively stabilized on impaired mitochondria to activate parkin. PloS Biol., 2010, 8, e1000298.
58. Matsuda, N.; Sato, S.; Shiba, K.; Okatsu, K.; Saisho, K.; Gautier, C.A.; Sou, Y.; Saiki, S.; Kawajiri, S.; Sato, F.; Kimura, M.; Komatsu, M.; Hattori, N.; Tanaka, K. PINK1 stabilized by mitochondrial depolarization recruits parkin to damaged mitochondria and activates latent parkin for mitophagy. J. Cell Biol., 2010, 189, 211-221.
59. Winklhofer, K.F.; Henn, I.H.; Kay-Jackson, P.C.; Heller, U.; Tatzelt, J. Inactivation of parkin by oxidative stress and C-terminal truncations. J. Biol. Chem., 2003, 278, 47199-47208.
60. Van Humbeeck, C.; Waelkens, E.; Corti, O.; Brice, A.; Vandenberghe, W. Parkin occurs in a stable, non-covalent, 110-kDa complex in brain. Eur. J. Neurosci., 2008, 27, 284-293.
61. Deffenbaugh, A.E.; Scaglione, K.M.; Zhang, L.; Moore, J.M.; Buranda, T.; Sklar, L.A.; Skowyra, D. Release of ubiquitin-charged Cdc34-S-Ub from the RING domain is essential for ubiquitination of the SCF(Cdc4)-bound substrate Sic1. Cell, 2003, 114, 611-622. (Pubitemid 37159257)
62. Li, W.; Tu, D.; Brunger, A.T.; Ye, Y. A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate. Nature, 2007, 446, 333-337. (Pubitemid 46426147)
63. Windheim, M.; Peggie, M.; Cohen, P. Two different classes of E2 ubiquitinconjugating enzymes are required for the mono-ubiquitination of proteins and elongation by polyubiquitin chains with a specific topology. Biochem. J., 2008, 409, 723-729. (Pubitemid 351214198)
64. Hartmann-Petersen, R.; Gordon, C. Integral UBL domain proteins: a family of proteasome interacting proteins. Semin. Cell Dev. Biol., 2004, 15, 247-259. (Pubitemid 38251654)
65. Fallon, L.; Bélanger, C.M.L.; Corera, A.T.; Kontogiannea, M.; Regan- Klapisz, E.; Moreau, F.; Voortman, J.; Haber, M.; Rouleau, G.; Thorarinsdottir, T.; Brice, A.; van Bergen en Henegouwen, P.M.P.; Fon, E.A. A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K-Akt signalling. Nat. Cell Biol., 2006, 8, 834-842. (Pubitemid 44151586)
66. Sakata, E.; Yamaguchi, Y.; Kurimoto, E.; Kikuchi, J.; Yokoyama, S.; Yamada, S.; Kawahara, H.; Yokosawa, H.; Hattori, N.; Mizuno, Y.; Tanaka, K.; Kato, K. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep., 2003, 4, 301-306. (Pubitemid 36511728)
67. Um, J.W.; Im, E.; Lee, H.J.; Min, B.; Yoo, L.; Yoo, J.; Luebbert, H.; Stichel- Gunkel, C.; Cho, H.-S.; Chung, K.C. Parkin directly modulates 26S proteasome activity. J. Neurosci., 2010, 30, 11805-11814.
68. Safadi, S.S.; Shaw, G.S. Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15. J. Biol. Chem., 2010, 285, 1424-1434.
69. Confalonieri, S.; Salcini, A.E.; Puri, C.; Tacchetti, C.; DiFiore, P.P. Tyrosine phosphorylation of Eps15 is required for ligand-regulated, but not constitutive, endocytosis. J. Cell Biol., 2000, 150, 905-912.
70. Hofmann, K.; Falquet, L. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem. Sci., 2001, 26, 347-350. (Pubitemid 32530646)
71. Imai, Y.; Soda, M.; Takahashi, R. Parkin suppresses unfolded protein stressinduced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem., 2000, 275, 35661-35664.
72. Nuber, U.; Schwarz, S.E.; Scheffner, M. The ubiquitin-protein ligase E6- associated protein (E6-AP) serves as its own substrate. Eur. J. Biochem., 1998, 254, 643-649. (Pubitemid 28308117)
73. Yang, Y.; Fang, S.; Jensen, J.P.; Weissman, A.M.; Ashwell, J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science, 2000, 288, 874-877. (Pubitemid 30257739)
74. Jiang, J.; Ballinger, C.A.; Wu, Y.; Dai, Q.; Cyr, D.M.; Hohfeld, J.; Patterson, C. CHIP is a U-box-dependent E3 ubiquitin ligase. J. Biol. Chem., 2001, 276, 42938-42944.
75. Hampe, C.; Ardila-Osorio, H.; Fournier, M.; Brice, A.; Corti, O. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitinprotein ligase with monoubiquitylation capacity. Hum. Mol. Genet., 2006, 15, 2059-2075. (Pubitemid 43923396)
76. Wilkinson, K.A.; Henley, J.M. Mechanisms, regulation and consequences of protein SUMOylation. Biochem. J., 2010, 428, 133-145.
77. Um, J.W.; Chung, K.C. Functional modulation of parkin through physical interaction with SUMO-1. J. Neurosci. Res., 2006, 84, 1543-1554. (Pubitemid 44683147)
78. Alves da Costa, C.; Sunyach, C.; Giaime, E.; West, A.; Corti, O.; Brice, A.; Safe, S.; Abou-Sleiman, P.M.; Wood, N.W.; Takahashi, H.; Goldberg, M.S.; Shen, J.; Checler, F. Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease. Nat. Cell Biol., 2009, 11, 1370-1375.
79. Varela, I.; Cadiñanos, J.; Pendas, A.M.; Gutierrez-Fernandez, A.; Folgueras, A.R.; Sanchez, L.M.; Zhou, Z.; Rodriguez, F.J.; Stewart, C.L.; Vega, J.A.; Tryggvason, K.; Freije, J.M.; Lopez-Otin, C. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature, 2005, 437, 564-568. (Pubitemid 41613555)
80. Clark, I.E.; Dodson, M.W.; Jian, C.; Cao, J.H.; Huh, J.R.; Seol, J.H.; Yoo, S.J.; Hay, B.A.; Guo, M. Drosophila PINK1 is required for mitochondrial function and interacts genetically with parkin. Nature, 2006, 441, 1162-1166. (Pubitemid 43990738)
81. Park, J.; Lee, S.B.; Lee, S.; Kim, Y.; Song, S.; Kim, S.; Bae, E.; Kim, J.; Shong, M.; Kim, J.M.; Chung, J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature, 2006, 441, 1157-1161. (Pubitemid 43990737)
82. Narendra, D.; Tanaka, A.; Suen, D.F.; Youle, R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell Biol., 2008, 183, 795-803.
83. Vives-Bauza, C.; Zhou, C.; Huang, Y.; Cui, M.; de Vries, R.L.A.; Kim, J.; May, J.; Tocilescu, M.A.; Liu, W.; Ko, H.S.; Magrane, J.; Moore, D.J.; Dawson, V.L.; Grailhe, R.; Dawson, T.M.; Li, C.; Tieu, K.; Przedborski, S. PINK1-dependent recruitment of parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. USA, 2010, 107, 378-383.
84. Lee, J.Y.; Nagano, Y.; Taylor, J.P.; Lim, K.L.; Yao, T.P. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation and HDAC6-dependent mitophagy. J. Cell Biol., 2010, 189, 671-679.
85. Kim, Y.; Park, J.; Kim, S.; Song, S.; Kwon, S.-K.; Lee, S.-H.; Kitada, T.; Kim, J.-M.; Chung, J. PINK1 controls mitochondrial localization of parkin through direct phosphorylation. Biochem. Biophys. Res. Commun., 2008, 377, 975-980.
86. Manning, G.; Whyte, D.B.; Martinez, R.; Hunter, T.; Sudarsanam, S. The protein kinase complement of the human genome. Science, 2002, 298, 1912-1934. (Pubitemid 35425239)
87. Bueler, H. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease. Exp. Neurol., 2009, 218, 235-246.
88. Cha, G.H.; Kim, S.; Park, J.; Lee, E.; Kim, M.; Lee, S.B.; Kim, J.M.; Chung, J.; Cho, K.S. Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila. Proc. Natl. Acad. Sci. USA, 2005, 102, 10345-10350. (Pubitemid 41023373)
89. Liu, M.; Aneja, R.; Sun, X.; Xie, S.; Wang, H.; Wu, X.; Dong, J.-T.; Li, M.; Joshi, J.C.; Zhou, J. Parkin regulates eg5 expression by hsp70 ubiquitinationdependent inactivation of c-Jun NH2-terminal kinase. J. Biol. Chem., 2008, 283, 35783-35788.
90. Ren, Y.; Jiang, H.; Yang, F.; Nakaso, K.; Feng, J. Parkin protects dopaminergic neurons against microtubule-depolymerizing toxins by attenuating microtubule-associated protein kinase activation. J. Biol. Chem., 2009, 284, 4009-4017.
91. Xia, X.G.; Harding, T.; Weller, M.; Bieneman, A.; Uney, J.B.; Schulz, J.B. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. Natl. Acad. Sci. USA, 2001, 98, 10433-10438. (Pubitemid 32803037)
92. Imam, S.Z.; Zhou, Q.; Yamamoto, A.; Valente, A.J.; Ali, S.F.; Bains, M.; Roberts, J.L.; Kahle, P.J.; Clark, R.A.; Li, S. Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J. Neurosci., 2011, 31, 157-163.
93. Shin, J.H.; Ko, H.S.; Kang, H.; Lee, Y.; Lee, Y.I.; Pletinkova, O.; Troconso, J.C.; Dawson, V.L.; Dawson, T.M. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease. Cell, 2011, 144, 689-702.